Vaxil Bio (TSXV:VXL) Beginning Cash Position : C$0.67 Mil (As of Jun. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Vaxil Bio Beginning Cash Position?

Vaxil Bio's Beginning Cash Position for the quarter that ended in Jun. 2024 was C$0.67 Mil.

Vaxil Bio's quarterly Beginning Cash Position declined from Dec. 2023 (C$1.01 Mil) to Mar. 2024 (C$0.94 Mil) and declined from Mar. 2024 (C$0.94 Mil) to Jun. 2024 (C$0.67 Mil).

Vaxil Bio's annual Beginning Cash Position increased from Dec. 2021 (C$1.51 Mil) to Dec. 2022 (C$2.24 Mil) but then declined from Dec. 2022 (C$2.24 Mil) to Dec. 2023 (C$1.51 Mil).

Vaxil Bio Beginning Cash Position Historical Data

The historical data trend for Vaxil Bio's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaxil Bio Beginning Cash Position Chart

Vaxil Bio Annual Data

Trend

May14

May15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

0.75

0.08

1.51

2.24

1.51

Vaxil Bio Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Beginning Cash Position	Get a 7-Day Free Trial															1.34	1.06	1.01	0.94	0.67

Vaxil Bio Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Vaxil Bio Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Vaxil Bio's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaxil Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vaxil Bio Ltd (TSXV:VXL) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

3400 One First Canadian Place, Toronto, ON, CAN, M5X 1A4

Website

https://www.vaxil-bio.com

Vaxil Bio Ltd is an Israeli immunotherapy biotech company focused on a novel drug discovery and development platform based on Signal Peptides which the company deploys to fight infectious diseases and cancer.

Executives

Gadi Levin

Director, Senior Officer

Vaxil Bio Headlines

No Headlines